Atlantic Bone Screen
Private Company
Funding information not available
Overview
Atlantic Bone Screen operates as a preclinical CRO, historically expert in bone physiology, now offering a broad portfolio of validated models and analytical services across multiple therapeutic areas. The company positions itself as a reliable and responsive partner for biotechs, pharma, and academic sponsors, emphasizing scientific advice, customized protocols, and high-quality data interpretation. Its strategic direction involves expanding its service offerings and maintaining a strong focus on animal ethics and scientific expertise to support the global drug development pipeline.
Technology Platform
Integrated preclinical service platform offering validated in vitro cell assays, in vivo animal models, and a comprehensive suite of ex vivo analytical services including specialized histology, histomorphometry, preclinical imaging, and biomarker analysis.
Opportunities
Risk Factors
Competitive Landscape
Competes with large global CROs (e.g., Charles River, Labcorp) and niche specialists. Differentiates through deep expertise in bone biology and histology, high-touch scientific collaboration, flexible protocol customization, and a strong emphasis on animal ethics and data interpretation quality.